24 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... #management #pharmacology ... #IDSA
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management
Massive Hemoptysis - Diagnosis and Management
 • Definitions: 
   - Hemoptysis = bleeding from
Diagnosis and Management ... bleeding (>1OO ml ... • Airway Management ... #treatment #workup ... #pulmonary #criticalcare
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Framework and Management ... Definition: 150-600 mL ... Primary Vascular: Pulmonary ... Coagulopathy Initial Management ... #pulmonary #criticalcare
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
Pulmonary Embolism ... Treatment Systemic ... #Embolism #Treatment ... #AcutePE #Management ... #CriticalCare
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Hypoxemia - Workup and Management ... Aspiration, Flash Pulmonary ... Bronchospasm, Pulmonary ... Workup #diagnosis #Management ... #treatment #criticalcare
Severe Asthma Exacerbation
Signs of a Severe Asthma Exacerbation:
 • Vitals: ↑HR ↑RR ↓SpO2
 • High work
of baseline Treatments ... #Exacerbation #CriticalCare ... #pulmonary #ventilation ... #mechanical #management ... #treatment
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
• Obstructive: Pulmonary ... Dehydration Shock Treatment ... Differential #Diagnosis #criticalcare ... #algorithm #treatment ... #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... for effective treatment ... candida #mucosal #IDSA ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic